UKHSA and Stablepharma highlight breakthrough with fridge-free tetanus and diphtheria vaccine

• Stablepharma has developed a thermostable tetanus and diphtheria vaccine requiring no cold-chain storage, addressing a critical logistical barrier to immunisation in resource-limited and emergency settings
• Room-temperature stability eliminates refrigeration dependency, enabling rapid vaccine deployment during humanitarian crises and improving accessibility in low-income regions with inadequate cold-chain infrastructure
• UKHSA endorsement signals potential for broader application of thermostable technology across other vaccines, with implications for NHS emergency preparedness and international immunisation programmes

'Fridge-free' vaccines have huge potential for vaccine delivery in emergency response situations and the developing world.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.